Ella

BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM

Retrieved on: 
Wednesday, March 15, 2023

MINNEAPOLIS, March 15, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its participation in the Cell and Gene Therapy Catapult Process Analytical Technology (Catapult PAT) consortium, a multi-year collaboration involving 24 partner companies, technology providers, therapy developers, and charities.

Key Points: 
  • MINNEAPOLIS, March 15, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its participation in the Cell and Gene Therapy Catapult Process Analytical Technology (Catapult PAT) consortium, a multi-year collaboration involving 24 partner companies, technology providers, therapy developers, and charities.
  • The Catapult PAT consortium is the first initiative of this scale and functional expertise with member companies and organizations collaborating to develop cell and gene therapy-specific process analytical technologies.
  • With its robust performance in this project, the Cell and Gene Therapy Catapult plans to incorporate Ella™ into an existing CGT Catapult facility to further support scientists in the UK.
  • Established by Innovate UK, the Cell and Gene Therapy Catapult fosters collaborations between academia, industry, and healthcare providers to develop new technology and drive innovation.

Tory Burch Turns to Modern Meadow Bio-Alloy™ For Ella Bio Tote

Retrieved on: 
Tuesday, February 28, 2023

NUTLEY, N.J., Feb. 28, 2023 /PRNewswire/ -- Modern Meadow, a purpose-driven biotechnology company revolutionizing consumer goods, today announced its Bio-Alloy™ proprietary protein-based technology is coming to the Tory Burch runway as the American fashion brand debuts its first-ever plant-based leather alternative tote, the Ella Bio, an evolution of the iconic Ella tote.

Key Points: 
  • NUTLEY, N.J., Feb. 28, 2023 /PRNewswire/ -- Modern Meadow , a purpose-driven biotechnology company revolutionizing consumer goods, today announced its Bio-Alloy™ proprietary protein-based technology is coming to the Tory Burch runway as the American fashion brand debuts its first-ever plant-based leather alternative tote, the Ella Bio, an evolution of the iconic Ella tote.
  • Tory Burch debuts its first plant-based leather alternative tote, the Ella Bio, powered by Modern Meadow technology.
  • The Tory Burch partnership is the latest for Modern Meadow, which is working to scale the availability of plant-based textiles for the fashion industry through partnerships with renowned suppliers and luxury brands.
  • "Consumer demand for products that are good for the planet is ever accelerating," said Catherine Roggero-Lovisi, CEO of Modern Meadow.

BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS

Retrieved on: 
Tuesday, October 11, 2022

MINNEAPOLIS, Oct. 11, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and PROGEN announced today the release of three new Simple Plex™ Adeno-Associated Virus (AAV) viral titer assays for intact AAV capsid quantification. Featuring best-in-class AAV reagents from PROGEN—a leader in AAV antibodies, ELISAs, and controls—the new Simple Plex AAV1, AAV6, and AAV8 viral titer assays provide users with a fully automated and quantitative method of vector analysis.

Key Points: 
  • MINNEAPOLIS, Oct. 11, 2022 /PRNewswire/ --Bio-Techne Corporation (NASDAQ: TECH) and PROGEN announced today the release of three new Simple Plex Adeno-Associated Virus (AAV) viral titer assays for intact AAV capsid quantification.
  • Featuring best-in-class AAV reagents from PROGENa leader in AAV antibodies, ELISAs, and controlsthe new Simple Plex AAV1, AAV6, and AAV8 viral titer assays provide users with a fully automated and quantitative method of vector analysis.
  • The new Simple Plex AAV viral titer assays offer the same superior performance as the industry standard PROGEN AAV ELISAs along with the sensitivity, reproducibility, convenience and time-saving advantages inherent in the fully automated Ella immunoassay platform.
  • "The improved range of detection achievable with our Simple Plex viral titer assays is particularly useful for AAV capsid titer assessment, as samples need fewer dilutions to meet the linear range of the assay.

ACOUSTIC SOUNDS, VERVE/UMe's ACCLAIMED AUDIOPHILE VINYL REISSUE SERIES, TO DELIVER MORE DEFINITIVE PRESSINGS OF SOME OF THE LABEL'S BEST-KNOWN JAZZ ALBUMS AS IT ENTERS ITS THIRD YEAR

Retrieved on: 
Thursday, May 5, 2022

LOS ANGELES, May 5, 2022 /PRNewswire/ -- Since launching in 2020, Verve/UMe's all-analog vinyl reissue series, Acoustic Sounds, has provided definitive, best-in-class audiophile grade pressings of some of the most important and beloved jazz records of all time, each mastered from the original tapes and produced with the utmost care. The nearly two dozen releases to date feature many of the timeless, classic albums from the Verve Label Group's stable of labels including Decca, EmArcy, Impulse! Records, Philips Records and Verve, and thus far have included Bill Evans' Trio '64, Clifford Brown and Max Roach's A Study In Brown, Gil Evans Orchestra's Out of the Cool, John Coltrane's A Love Supreme and Ballads, Louis Armstrong and Oscar Peterson's Louis Armstrong Meets Oscar Peterson, Nina Simone's I Put a Spell on You and Pastel Blues, Oliver Nelson's Blues And The Abstract Truth, Peggy Lee's Black Coffee and Sarah Vaughan's Sarah Vaughan, and Stan Getz and João Gilberto's Getz/Gilberto.

Key Points: 
  • The nearly two dozen releases to date feature many of the timeless, classic albums from the Verve Label Group's stable of labels including Decca, EmArcy, Impulse!
  • but will also feature several important albums released by Verve between 1956-65.
  • Ella Fitzgerald and Louis Armstrong's immortal duets albums will follow with Ella & Louis (1956) on July 15 and Ella & Louis Again (1957) on September 16.
  • All albums will be pressed on 180-gram vinyl and packaged in high-quality tip-on gatefold jackets, replicating the original packaging.

BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY

Retrieved on: 
Tuesday, April 12, 2022

Utilizing a cartridge-based microfluidic design, the new Simple Plex HEK 293 HCP 3G assay provides consistent and controlled assay conditions for HCP detection that is exceptionally accurate and reproducible.

Key Points: 
  • Utilizing a cartridge-based microfluidic design, the new Simple Plex HEK 293 HCP 3G assay provides consistent and controlled assay conditions for HCP detection that is exceptionally accurate and reproducible.
  • Cygnus Technologies' HEK 293 HCP ELISA Kit, 3G is considered the gold standard in HEK 293 HCP impurity quantification.
  • The Simple Plex HEK 293 HCP 3G assay features the same HEK 293 HCP antibodies from industry leader Cygnus Technologies, ensuring the broad HCP detection coverage and industry recognized specificity of the Cygnus ELISA, along with the workflow advantages of the automated Ella platform.
  • The new Simple Plex HEK 293 HCP 3G assay provides an automation solution for fast and efficient bioprocess impurity testing to address our customer needs."

MediLogix Announces Integration with PointClickCare's EHR Platform

Retrieved on: 
Tuesday, December 14, 2021

Their integration with PointClickCare automates returns at the time of patient discharge, all in a single, game-changing service for its customers.

Key Points: 
  • Their integration with PointClickCare automates returns at the time of patient discharge, all in a single, game-changing service for its customers.
  • "The RaaS integration with PointClickCare automates the return of rental equipment upon patient discharge," said Harry Felber, President and CEO of MediLogix.
  • The Ella asset management application provides real time equipment information and the integration with PointClickCare ensures equipment is returned upon discharge.
  • Additional information regarding the integration can be found on the PointClickCare Marketplace an online platform that enables customers to easily evaluate authorized third-party technology partners.

Patterson Legal Group Announces the Addition of a New Attorney to its Kansas Personal Injury Law Firm

Retrieved on: 
Thursday, November 11, 2021

Monique Centeno graduated from Washburn University School of Law in 2005 and is licensed to practice in the state of Kansas.

Key Points: 
  • Monique Centeno graduated from Washburn University School of Law in 2005 and is licensed to practice in the state of Kansas.
  • For media inquiries about Monique Centeno joining Patterson Legal Group, please contact Ella Reusser at (888) 687-2400 or via email at [email protected] .
  • Patterson Legal Group is a personal injury law firm with offices located throughout Kansas and Missouri.
  • Learn more about the specific legal services and community outreach activities of Patterson Legal Group at PattersonLegalGroup.com .

Dickinson College Agrees to Reinstate Women's Squash Team, Stop Discriminating Against Female Student-Athletes, and Comply with Title IX

Retrieved on: 
Thursday, October 7, 2021

The settlement leaves open the option for Dickinson to reinstate the recently-eliminated men's squash team, which would strengthen Dickinson's squash program as a whole.

Key Points: 
  • The settlement leaves open the option for Dickinson to reinstate the recently-eliminated men's squash team, which would strengthen Dickinson's squash program as a whole.
  • "Title IX has been the law for almost 50 years and Dickinson College has been flagrantly violating it.
  • Dickinson will reinstate the women's team it illegally tried to eliminate, develop a gender equity plan with an expert approved by the squash team members, stop discriminating against its female student-athletes, and bring all aspects of the intercollegiate athletic program into compliance with Title IX."
  • Women's squash team co-captain Courtney Trail said, "Six weeks ago, Dickinson College violated Title IX by announcing it was eliminating our team.

Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay

Retrieved on: 
Wednesday, July 28, 2021

Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella instruments, its multiplexing immunoassay system.

Key Points: 
  • Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella instruments, its multiplexing immunoassay system.
  • Featuring antibodies from PROGEN, the Simple Plex AAV2 viral titer assay detects assembled viral capsids as well as the comprehensively characterized AAV2 standard to deliver industry leading specificity.
  • Available on the Ella platform, the Simple Plex AAV2 assay utilizes the recombinant AAV2 antibody (A20R) from industry leader PROGEN to quantify assembled AAV2 capsids.
  • "Working with ProteinSimple to develop the Simple Plex AAV2 assay was a great experience," said Katja Betts, CEO of PROGEN.

Patterson Legal Group Gives Away Up to 100 Backpacks with School Supplies to K-12 Students at Their St. Joseph Law Office

Retrieved on: 
Thursday, July 15, 2021

Families with K-12 students are invited to park and pick up a free backpack with school supplies.

Key Points: 
  • Families with K-12 students are invited to park and pick up a free backpack with school supplies.
  • Quantities are limited to around 100 backpacks with supplies, and will be handed out one per student on a first-come, first-served basis, while supplies last.
  • For more information about the Patterson Legal Group backpack giveaways, please contact Ella Reusser with Patterson Legal Group at (888) 687-2400, or via email at [email protected] .
  • Learn more about the specific legal services and community outreach activities of Patterson Legal Group at pattersonlegalgroup.com .